With state-of-the-art laboratories in Canada, North America, we offer excellent opportunities for our customers to develop fully optimized synthetic processes both for the lead API molecules as well as generic API molecules and their intermediates. We also provide custom synthesis of molecules related to biotech and agrochemical industry. We offer process development for our customers at competitive price.
We have years of experience developing processes for APIs and intermediates. We also have experience in drug delivery molecules. Our expertise comes from the experience acquired at well-known pharmaceutical companies and premier educational and research institutions in the US, Canada and abroad. Our R&D capabilities allow us to offer efficient process development of pharmaceutical molecules and intermediates as well as other organic molecules.
Nadeem Hashmi, PhD
Chief Scientific Officer
Dr. Nadeem Hashmi carried out his PhD work at the Central Drug Research Institute, Lucknow, India. He served on the R&D teams of several major pharmaceutical companies in India including Ranbaxy Research Laboratories and Morepen Laboratories. He, later, led the API Process Development Division of Halo Pharmaceuticals Inc, Canada. While at the different pharmaceutical companies, he worked on a wide variety of API molecules including antibiotic, anti-viral, anti-diabetic, anti-asthmatic, anti-arthritic drugs etc. During his stay at the prestigious Duke University, Durham, NC, USA, Dr. Nadeem Hashmi spent his time developing anti-viral molecules, modified oligonucleotides, and gene- and drug-delivery vehicles. He has more than 20 years of R&D experience in pharmaceutical industry and academia and has published many research papers on drug development, gene/drug delivery, peptides, nucleosides, nucleotides and oligonucleotides synthesis and applications in reputed international journals.